1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Complication risk not related to timing between rituximab, surgery for RA patients – Healio

June 21, 2013Monoclonal Anti-CD20 Antibodiesadmin

Complication risk not related to timing between rituximab, surgery for RA patients
Healio
Jérémie Sellam, MD, PhD, of the department of rheumatology, University of Paris VI, and colleagues studied 133 patients with rheumatoid arthritis (RA; median age, 59 years) who underwent 140 procedures within 1 year of rituximab (RTX) infusion and had ...

Post navigation

← Picture desk live: the best news photographs of the day – The Guardian HPV Antibodies Signal Higher Risk for Oropharyngeal Cancer – Monthly Prescribing Reference →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos